We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+10.53%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$6.59B
AUM Growth
-$836M
Cap. Flow
-$48.4M
Cap. Flow %
-0.73%
Top 10 Hldgs %
15.06%
Holding
1,801
New
509
Increased
232
Reduced
294
Closed
676

Sector Composition

Rank Sector Weight
1 Miscellaneous 87.61%
2 Healthcare 2.74%
3 Communication Services 2.58%
4 Financials 2.16%
5 Technology 1.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSCO icon
26
PUT
Tractor Supply
TSCO
$16.8B
$41.9M 0.64%
+800,000
New +$38.2M
FTAI icon
27
CALL
FTAI Aviation
FTAI
$19.6B
$41.4M 0.63%
614,600
+316,200
+106% +$17.4M
BHC icon
28
CALL
Bausch Health
BHC
$2.12B
$41M 0.62%
3,861,600
+2,304,800
+148% +$20.2M
JPM icon
29
PUT
JPMorgan Chase
JPM
$929B
$40.1M 0.61%
+200,000
New +$36.1M
W icon
30
CALL
Wayfair
W
$14B
$39.7M 0.6%
585,000
+285,000
+95% +$16.1M
CPRI icon
31
CALL
Capri Holdings
CPRI
$1.68B
$38.3M 0.58%
846,400
+596,400
+239% +$28.4M
PDD icon
32
PUT
Pinduoduo
PDD
$112B
$36.8M 0.56%
316,400
+66,000
+26% +$8.65M
X
33
CALL
DELISTED
US Steel
X
$35.6M 0.54%
874,200
+44,200
+5% +$2.02M
VKTX icon
34
CALL
Viking Therapeutics
VKTX
$3.38B
$35.6M 0.54%
434,000
+324,000
+295% +$14.4M
MSTR icon
35
CALL
Strategy Inc
MSTR
$61.1B
$34.4M 0.52%
+202,000
New +$18.4M
ITCI
36
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$34M 0.52%
490,900
+460,900
+1,536% +$31.7M
CYTK icon
37
CALL
Cytokinetics
CYTK
$9.56B
$33.4M 0.51%
475,900
-876,000
-65% -$67.8M
CLS icon
38
CALL
Celestica
CLS
$41.9B
$32.7M 0.5%
728,500
+552,000
+313% +$21M
VST icon
39
PUT
Vistra
VST
$47.2B
$31.3M 0.48%
450,100
+2,900
+0.6% +$143K
GS icon
40
CALL
Goldman Sachs
GS
$274B
$31.3M 0.48%
75,000
+15,000
+25% +$5.82M
BBIO icon
41
CALL
BridgeBio Pharma
BBIO
$13B
$30.6M 0.46%
989,000
+928,700
+1,540% +$31.6M
WDC icon
42
CALL
Western Digital
WDC
$159B
$29.2M 0.44%
566,244
+202,419
+56% +$8.86M
XOM icon
43
PUT
ExxonMobil
XOM
$672B
$28.7M 0.44%
+247,000
New +$25.8M
IBM icon
44
PUT
IBM
IBM
$216B
$28.6M 0.44%
+150,000
New +$27.4M
CFLT
45
CALL
DELISTED
Confluent
CFLT
$27.7M 0.42%
+906,800
New +$25.6M
LOPE icon
46
PUT
Grand Canyon Education
LOPE
$3.94B
$27.2M 0.41%
+200,000
New +$26.1M
OKE icon
47
CALL
Oneok
OKE
$58.9B
$26.9M 0.41%
335,700
+294,700
+719% +$21.5M
ARM icon
48
CALL
Arm
ARM
$294B
$26.6M 0.4%
+212,800
New +$22.6M
CRSP icon
49
CALL
CRISPR Therapeutics
CRSP
$5.47B
$26.2M 0.4%
385,000
-195,700
-34% -$14M
META icon
50
Meta Platforms (Facebook)
META
$1.7T
$25.5M 0.39%
52,557
+33,557
+177% +$15M

Similar funds

Caption Management's Q1 2024 Portfolio in Review

As of Q1 2024, Caption Management held 1,801 positions worth $6.59B, down 11% from $7.42B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Caption Management's Q1 2024 filing shows 509 new, 232 increased, 294 reduced and 676 closed positions. Its largest new stake was Adobe: 22,800 shares worth $11.5M. The largest sale was Apellis Pharmaceuticals, an estimated $23.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, down from 89% a quarter earlier, followed by Healthcare and Communication Services.

  • Caption Management's largest Q1 2024 buy was Adobe: 22,800 shares worth $11.5M.
  • Caption Management added most to Sarepta Therapeutics in Q1 2024, an estimated $18.4M increase.
  • Caption Management's biggest Q1 2024 reduction was Apellis Pharmaceuticals, cutting an estimated $23.1M.
  • Caption Management fully exited Palo Alto Networks in Q1 2024, selling an estimated $20.9M.
  • Caption Management's ten largest holdings make up 15% of its $6.59B portfolio in Q1 2024.
  • Caption Management opened 509 new positions and closed 676 in Q1 2024.
  • Caption Management's portfolio value fell 11% quarter-over-quarter to $6.59B.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.